Significance of Combined Analysis of Seven Biomarkers in the Diagnosis of Pancreatic Cancer
WU Zong-yong,QI Jun,LI Xue-xiang,JIA De-qiang,ZHANG Zhen-jie,MU Jian-Jun,ZHANG Chun,LI Zhen-sheng
DOI: https://doi.org/10.3969/j.issn.1006-1703.2008.06.003
2008-01-01
Abstract:To evaluate the clinical significance of combined analysis of seven biomarkers in the diagnosis of pancreatic cancer,the serum CA19-9,CA242,CEA,β2-MG,PALB,Fib and D-D levels were detected in 125 patients with pancreatic cancer,48 patients with liver metastasis of pancreatic cancer,40 patients with benign pancreatic tumor and 60 healthy controls by CLIA,ELISA,coagulation point detection method and biochemistry assay.The results showed that the combined measurement of CA19-9,CA242,CEA,β2-MG,PALB,Fib and D-D could increase the diagnostic sensitivity of pancreatic carcinoma to 96.0%.There was no statistics significance in Fib levels with tissue grading number increasing(P>0.05),but the CA19-9,CA242,CEA,β2-MG,PALB and D-D levels had statistics significance(P<0.05).The serum levels of CA19-9,CA242,CEA,β2-MG,Fib and D-D in patients with pancreatic cancer and liver metastasis of pancreatic cancer were increased,while the serum PALB level was decreased.The combined measurement of these biomarkers could increase the sensitivity in the diagnosis of pancreatic carcinoma.